Cart
sales@molnova.com
Methyl palmitoleate
CAS No. 1120-25-8
Methyl palmitoleate( —— )
Catalog No. M21476 CAS No. 1120-25-8
Palmitoleic acid methyl ester is an ester version of palmitoleic acid an ω-7 monounsaturated fatty acid that is a common constituent of the triglycerides of human adipose tissue.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethyl palmitoleate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPalmitoleic acid methyl ester is an ester version of palmitoleic acid an ω-7 monounsaturated fatty acid that is a common constituent of the triglycerides of human adipose tissue.
-
DescriptionPalmitoleic acid methyl ester is an ester version of palmitoleic acid an ω-7 monounsaturated fatty acid that is a common constituent of the triglycerides of human adipose tissue.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1120-25-8
-
Formula Weight268.4
-
Molecular FormulaC17H32O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:30mg/ml(111.77mM)
-
SMILESCCCCCC/C=C\CCCCCCCC(OC)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nestel P. et al. Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J. Lipid Res. 35(4) 656-662 (1994).
molnova catalog
related products
-
Lyciumin B
Lyciumin B is a cyclic peptide isolated from Lysium chinense.
-
FM04
FM04 is an orally active and highly potent inhibitor of P-glycoprotein (P-gp) with an EC50 value of 83 nM. FM04 can interact with Q1193 and I1115 in human P-gp nucleotide binding domain 2 (NBD2).
-
PACMA 31
PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.
